Two Sigma Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
152,500
-2,100
| -1% | -$32.5K | ﹤0.01% | 1037 |
|
|
2025
Q1 | $2.3M | Hold |
154,600
| – | – | 0.01% | 1103 |
|
|
2024
Q4 | $2.05M | Buy |
154,600
+121,500
| +367% | +$1.61M | ﹤0.01% | 1114 |
|
|
2024
Q3 | $471K | Buy |
+33,100
| New | +$471K | ﹤0.01% | 1736 |
|
|
2023
Q2 | – | Sell |
-87,900
| Closed | -$1.45M | – | 2653 |
|
|
2023
Q1 | $1.45M | Buy |
87,900
+56,991
| +184% | +$939K | ﹤0.01% | 1444 |
|
|
2022
Q4 | $482K | Sell |
30,909
-86,491
| -74% | -$1.35M | ﹤0.01% | 1891 |
|
|
2022
Q3 | $1.52M | Sell |
117,400
-62,057
| -35% | -$805K | ﹤0.01% | 1314 |
|
|
2022
Q2 | $2.52M | Buy |
179,457
+37,557
| +26% | +$527K | 0.01% | 1095 |
|
|
2022
Q1 | $2.03M | Buy |
+141,900
| New | +$2.03M | 0.01% | 1244 |
|
|
2021
Q2 | – | Sell |
-100,800
| Closed | -$1.84M | – | 2687 |
|
|
2021
Q1 | $1.84M | Buy |
+100,800
| New | +$1.84M | 0.01% | 1306 |
|